Not only are biotech stocks subject to the boom-or-bust nature of their therapeutics, but they also operate in a cyclical ...

A multicenter study led by Cedars-Sinai created a database of adverse medication events—the fourth leading cause of death in ...

This article examines post-market drug safety, highlighting surveillance mechanisms, regulatory responses, and case studies of approved drugs with hidden risks.

The AI in pharmacovigilance market is expected to grow at a CAGR of 12–15% from 2023 to 2030, driven by the need to automate ...

Cedars-Sinai researchers developed OnSIDES, a free AI-driven global database of over 3.6 million adverse drug events, ...

A new comparison of approval data for first-in-class drugs approved by the US FDA and the EMA revealed that the FDA is more ...

ELIQUENT Life Sciences (ELIQUENT), a global regulatory, quality, and safety consulting firm, today announced the acquisition of Truliant Consulting ...

Carina Birt, Sarum Life Sciences Limited • Biologit for Local Literature™ delivers results 15 x faster than traditional searches, and is considerably more accurate and reliable • The new ...

Pentagon says Guam could be 1st target of Chinese missiles during Taiwan invasion ...